Among the emerging plasma biomarkers, p-tau phosphorylated at threonine 217 (p-tau217) has gained recognition for its high specificity and sensitivity in detecting neurodegenerative changes associated with AD [10,11]. The gene discussed is MAPT; the disease is Alzheimer disease.